RECURRENT VULVAR CANCER
Clinical trials for RECURRENT VULVAR CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT VULVAR CANCER trials appear
Sign up with your email to follow new studies for RECURRENT VULVAR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo offers hope for Hard-to-Treat vulvar cancer
Disease control Recruiting nowThis study tests whether two drugs, pembrolizumab and lenvatinib, can shrink tumors in people with vulvar cancer that has come back, spread, or cannot be removed by surgery or radiation. About 42 participants will receive the drug combination. The goal is to see how many patients…
Matched conditions: RECURRENT VULVAR CANCER
Phase: PHASE2 • Sponsor: AGO Research GmbH • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Electric pulses plus chemo could spare women from mutilating surgery
Disease control Recruiting nowThis study tests a treatment called electrochemotherapy for women whose vulvar cancer has come back. It combines a chemotherapy drug with electric pulses to help the drug enter cancer cells more effectively. The goal is to shrink tumors and reduce the need for major surgery, whic…
Matched conditions: RECURRENT VULVAR CANCER
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated May 14, 2026 12:05 UTC